Literature DB >> 24941889

Human pancreas endocrine cell populations and activating ABCC8 mutations.

Kanetee Busiah1, Virginie Verkarre, Hélène Cavé, Raphael Scharfmann, Michel Polak.   

Abstract

BACKGROUND/AIMS: Activating mutations in the ABCC8 gene encoding the KATP channel subunit SUR1 cause β-cell dysfunction with non-autoimmune diabetes mellitus in neonates or infants. We investigated whether activating ABCC8 mutations affect endocrine pancreas development.
METHODS: We studied a male infant with compound heterozygous ABCC8 mutations (p.Arg826Trp/p.Ile93Thr) causing neonatal diabetes mellitus. He died of ketoacidosis. Postmortem pancreas specimens were evaluated by fluorescent microscopy after immunostaining for insulin, glucagon, somatostatin, and PCNA, and Hoechst 33342 nuclear staining. We compared the findings to those in 5 age-matched controls.
RESULTS: The number of islets was decreased and the number of single or small clusters of insulin cells increased in the patient compared to the age-matched controls. The islets in the patient had an insulin-cell core surrounded by intermingled glucagon and somatostatin cells. The insulin/Hoechst surface ratio was decreased and the glucagon/Hoechst surface ratio increased in the patient (4.3 and 8.8%, respectively) versus the controls (8.2 and 3.1%, respectively). Somatostatin surface staining was similar in the patient and controls (4 vs. 4.7%). PCNA staining was increased 3- to 3.5-fold, indicating increased insulin-cell proliferation compared to controls.
CONCLUSION: Activating ABCC8 mutations impaired the balance between β and α cells in the patient, suggesting an effect on β-cell mass development.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24941889     DOI: 10.1159/000360004

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  7 in total

Review 1.  Islet formation in mice and men: lessons for the generation of functional insulin-producing β-cells from human pluripotent stem cells.

Authors:  Gopika Nair; Matthias Hebrok
Journal:  Curr Opin Genet Dev       Date:  2015-04-21       Impact factor: 5.578

2.  Pancreatic Histopathology of Human Monogenic Diabetes Due to Causal Variants in KCNJ11, HNF1A, GATA6, and LMNA.

Authors:  May Sanyoura; Laura Jacobsen; David Carmody; Daniela Del Gaudio; Gorka Alkorta-Aranburu; Kelly Arndt; Ying Hu; Frances Kobiernicki; Irina Kusmartseva; Mark A Atkinson; Louis H Philipson; Desmond Schatz; Martha Campbell-Thompson; Siri Atma W Greeley
Journal:  J Clin Endocrinol Metab       Date:  2018-01-01       Impact factor: 5.958

3.  Preservation of Reduced Numbers of Insulin-Positive Cells in Sulfonylurea-Unresponsive KCNJ11-Related Diabetes.

Authors:  Siri Atma W Greeley; Mark C Zielinski; Ananta Poudel; Honggang Ye; Shivani Berry; Jerome B Taxy; David Carmody; Donald F Steiner; Louis H Philipson; Jamie R Wood; Manami Hara
Journal:  J Clin Endocrinol Metab       Date:  2017-01-01       Impact factor: 5.958

Review 4.  Neonatal Diabetes and the KATP Channel: From Mutation to Therapy.

Authors:  Frances M Ashcroft; Michael C Puljung; Natascia Vedovato
Journal:  Trends Endocrinol Metab       Date:  2017-03-03       Impact factor: 12.015

5.  Screening for neonatal diabetes at day 5 of life using dried blood spot glucose measurement.

Authors:  Timothy J McDonald; Rachel E Besser; Mandy Perry; Tarig Babiker; Bridget A Knight; Maggie H Shepherd; Sian Ellard; Sarah E Flanagan; Andrew T Hattersley
Journal:  Diabetologia       Date:  2017-08-05       Impact factor: 10.122

Review 6.  New insights into KATP channel gene mutations and neonatal diabetes mellitus.

Authors:  Tanadet Pipatpolkai; Samuel Usher; Phillip J Stansfeld; Frances M Ashcroft
Journal:  Nat Rev Endocrinol       Date:  2020-05-06       Impact factor: 43.330

7.  Parental experiences of a diagnosis of neonatal diabetes and perceptions of newborn screening for glucose: a qualitative study.

Authors:  Maggie Shepherd; Bridget A Knight; Katherine Laskey; Timothy James McDonald
Journal:  BMJ Open       Date:  2020-11-04       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.